HK1029099A1 - 2-amino-6-methyl-7-acetyl-tetraline and pharmaceutical compositions for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies - Google Patents
2-amino-6-methyl-7-acetyl-tetraline and pharmaceutical compositions for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologiesInfo
- Publication number
- HK1029099A1 HK1029099A1 HK00106848A HK00106848A HK1029099A1 HK 1029099 A1 HK1029099 A1 HK 1029099A1 HK 00106848 A HK00106848 A HK 00106848A HK 00106848 A HK00106848 A HK 00106848A HK 1029099 A1 HK1029099 A1 HK 1029099A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- inflammatory
- prevention
- pharmaceutical compositions
- therapeutic treatment
- tetraline
- Prior art date
Links
- 230000002757 inflammatory effect Effects 0.000 title abstract 3
- 230000007170 pathology Effects 0.000 title abstract 3
- 230000001363 autoimmune Effects 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- ISWMKVVVEVKRMT-UHFFFAOYSA-N 1-(7-amino-3-methyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethanone Chemical compound C1C(N)CCC2=C1C=C(C(=O)C)C(C)=C2 ISWMKVVVEVKRMT-UHFFFAOYSA-N 0.000 title 1
- LCGFVWKNXLRFIF-UHFFFAOYSA-N 1,2,3,4-tetrahydronaphthalen-2-amine Chemical class C1=CC=C2CC(N)CCC2=C1 LCGFVWKNXLRFIF-UHFFFAOYSA-N 0.000 abstract 1
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 206010040070 Septic Shock Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000036303 septic shock Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT97RM000568A IT1294931B1 (it) | 1997-09-22 | 1997-09-22 | Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella |
| PCT/IT1998/000252 WO1999015494A1 (en) | 1997-09-22 | 1998-09-22 | 2-aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1029099A1 true HK1029099A1 (en) | 2001-03-23 |
Family
ID=11405257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK00106848A HK1029099A1 (en) | 1997-09-22 | 2000-10-26 | 2-amino-6-methyl-7-acetyl-tetraline and pharmaceutical compositions for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US7041703B2 (xx) |
| EP (1) | EP1017667B1 (xx) |
| JP (1) | JP4181301B2 (xx) |
| KR (1) | KR100583805B1 (xx) |
| CN (1) | CN1145606C (xx) |
| AT (1) | ATE254595T1 (xx) |
| AU (1) | AU738565B2 (xx) |
| BR (1) | BR9812368A (xx) |
| CA (1) | CA2303943A1 (xx) |
| DE (1) | DE69819922T2 (xx) |
| DK (1) | DK1017667T3 (xx) |
| ES (1) | ES2210820T3 (xx) |
| HK (1) | HK1029099A1 (xx) |
| IT (1) | IT1294931B1 (xx) |
| NZ (1) | NZ503492A (xx) |
| PT (1) | PT1017667E (xx) |
| WO (1) | WO1999015494A1 (xx) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1294931B1 (it) * | 1997-09-22 | 1999-04-23 | Sigma Tau Ind Farmaceuti | Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella |
| IT1317049B1 (it) | 2000-06-23 | 2003-05-26 | Sigma Tau Ind Farmaceuti | Composti utili per la preparazione di medicamenti ad attivita'inibitrice della fosfodiesterasi iv. |
| IT1317050B1 (it) * | 2000-06-23 | 2003-05-26 | Sigma Tau Ind Farmaceuti | Tetraline 2,6,7-sostituite utili per la preparazione di un medicamentoad attivita' inibitrice della fosfodiesterasi iv. |
| SK2982003A3 (en) * | 2000-08-14 | 2004-10-05 | Teva Pharma | Preparation of risperidone |
| US7125904B2 (en) | 2002-10-11 | 2006-10-24 | Portela & C.A., S.A. | Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation |
| GB0504314D0 (en) * | 2005-03-02 | 2005-04-06 | Glaxo Group Ltd | Novel polymorph |
| CN101768086B (zh) * | 2008-12-29 | 2014-03-26 | 北京富龙康泰生物技术有限公司 | 氨基甲醇衍生物及其盐类化合物及其合成方法和其药物用途 |
| EP3681876A1 (en) | 2017-09-14 | 2020-07-22 | H. Hoffnabb-La Roche Ag | New compound useful in the manufacture of medicaments |
| CN115724758B (zh) * | 2021-08-24 | 2024-12-27 | 杭州中美华东制药有限公司 | 喜树碱衍生物中间体及其合成方法和利用中间体合成喜树碱衍生物的方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3919316A (en) * | 1974-08-05 | 1975-11-11 | Lilly Co Eli | 2-Aminodichlorotetralins |
| DE2752659A1 (de) * | 1976-12-07 | 1978-06-08 | Sandoz Ag | Neue tetralinderivate, ihre herstellung und verwendung |
| US4448990A (en) * | 1982-11-16 | 1984-05-15 | Eli Lilly And Company | Hydroxyaminotetralincarboxamides |
| DE3660959D1 (de) * | 1985-06-26 | 1988-11-24 | Smithkline Beckman Corp | Benz-trisubstituted 2-aminotetralins |
| IT1241988B (it) * | 1990-06-15 | 1994-02-02 | Sigma Tau Ind Farmaceuti | 2- amminotetraline-6, 7-sostituite attive come immunomodulanti e composizioni farmaceutiche che le contengono |
| IT1242043B (it) * | 1990-12-21 | 1994-02-02 | Sigma Tau Ind Farmaceuti | Derivati della 1,2,3,4,-tetraidronaftilammina ad attivita' nootropica e composizioni farmaceutiche che li contengono. |
| US5438150A (en) * | 1994-04-26 | 1995-08-01 | Syntex (U.S.A.) Inc. | Process for making 1-benzocycloalkyl-1,3-dihydroimidazole-2-thione derivatives |
| IT1278045B1 (it) * | 1995-03-09 | 1997-11-17 | Sigma Tau Ind Farmaceuti | Uso di 2-amminotetraline-6,7-sostituite per la preparazione di composizioni farmaceutiche atte al trattamento dello shock, e di |
| IT1290910B1 (it) * | 1997-02-03 | 1998-12-14 | Sigma Tau Ind Farmaceuti | 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive |
| IT1294932B1 (it) * | 1997-09-22 | 1999-04-23 | Sigma Tau Ind Farmaceuti | Uso di 2-amminotetraline-6,7 sostituite per la preparazione di composizioni farmaceutiche atte al trattamento di patologie |
| IT1294931B1 (it) * | 1997-09-22 | 1999-04-23 | Sigma Tau Ind Farmaceuti | Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella |
-
1997
- 1997-09-22 IT IT97RM000568A patent/IT1294931B1/it active IP Right Grant
-
1998
- 1998-09-22 WO PCT/IT1998/000252 patent/WO1999015494A1/en active IP Right Grant
- 1998-09-22 AU AU93662/98A patent/AU738565B2/en not_active Ceased
- 1998-09-22 CA CA002303943A patent/CA2303943A1/en not_active Abandoned
- 1998-09-22 CN CNB988104598A patent/CN1145606C/zh not_active Expired - Fee Related
- 1998-09-22 EP EP98946706A patent/EP1017667B1/en not_active Expired - Lifetime
- 1998-09-22 KR KR1020007003077A patent/KR100583805B1/ko not_active Expired - Fee Related
- 1998-09-22 NZ NZ503492A patent/NZ503492A/xx unknown
- 1998-09-22 PT PT98946706T patent/PT1017667E/pt unknown
- 1998-09-22 BR BR9812368-8A patent/BR9812368A/pt not_active Application Discontinuation
- 1998-09-22 JP JP2000512805A patent/JP4181301B2/ja not_active Expired - Fee Related
- 1998-09-22 DK DK98946706T patent/DK1017667T3/da active
- 1998-09-22 ES ES98946706T patent/ES2210820T3/es not_active Expired - Lifetime
- 1998-09-22 DE DE69819922T patent/DE69819922T2/de not_active Expired - Fee Related
- 1998-09-22 AT AT98946706T patent/ATE254595T1/de not_active IP Right Cessation
-
2000
- 2000-03-22 US US09/533,381 patent/US7041703B2/en not_active Expired - Fee Related
- 2000-10-26 HK HK00106848A patent/HK1029099A1/xx not_active IP Right Cessation
-
2001
- 2001-03-26 US US09/816,317 patent/US6849663B2/en not_active Expired - Fee Related
-
2003
- 2003-04-08 US US10/408,122 patent/US20030229148A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20030158266A1 (en) | 2003-08-21 |
| WO1999015494A1 (en) | 1999-04-01 |
| PT1017667E (pt) | 2004-04-30 |
| ITRM970568A1 (it) | 1999-03-22 |
| CA2303943A1 (en) | 1999-04-01 |
| ES2210820T3 (es) | 2004-07-01 |
| JP4181301B2 (ja) | 2008-11-12 |
| US20020123652A1 (en) | 2002-09-05 |
| DK1017667T3 (da) | 2004-03-29 |
| US6849663B2 (en) | 2005-02-01 |
| DE69819922D1 (de) | 2003-12-24 |
| AU9366298A (en) | 1999-04-12 |
| ATE254595T1 (de) | 2003-12-15 |
| CN1145606C (zh) | 2004-04-14 |
| AU738565B2 (en) | 2001-09-20 |
| EP1017667B1 (en) | 2003-11-19 |
| US20030229148A1 (en) | 2003-12-11 |
| BR9812368A (pt) | 2000-09-19 |
| KR20010030671A (ko) | 2001-04-16 |
| IT1294931B1 (it) | 1999-04-23 |
| EP1017667A1 (en) | 2000-07-12 |
| JP2001517649A (ja) | 2001-10-09 |
| KR100583805B1 (ko) | 2006-05-26 |
| CN1276782A (zh) | 2000-12-13 |
| US7041703B2 (en) | 2006-05-09 |
| NZ503492A (en) | 2002-08-28 |
| DE69819922T2 (de) | 2004-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU15299A (sh) | Farmaceutski sastavi | |
| DE69905368D1 (en) | Oxydiertes thymosin beta 4 | |
| IL117957A0 (en) | Pharmaceutical compositions for the treatment of impotence | |
| MX9709238A (es) | Formulaciones farmaceuticas y de dieta para la profilaxis y tratamiento de trastornos gastrointestinales. | |
| MY116595A (en) | Polycarboxylic based cross-linked copolymers | |
| PL323490A1 (en) | Tetralinic compounds exibiting acitity against multgiple-drug refractoriness | |
| IL127918A0 (en) | Novel amino sugar and related sugar derivatives of indolylopyrrolocarbazoles their use as antitumor agents and pharmaceutical formulations | |
| BG103714A (en) | Pararacetamol-containing tablet | |
| IL141486A0 (en) | Pharmaceutical compositions containing a cd2 binding agent | |
| AU5892399A (en) | 1, 2, 4-triazole-3-thione compounds | |
| HK1029099A1 (en) | 2-amino-6-methyl-7-acetyl-tetraline and pharmaceutical compositions for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies | |
| AU6682594A (en) | Treatment of septic shock | |
| ZA973622B (en) | Use of forms of hyaluronic acid (HA) for the treatment of cancer. | |
| IL126892A0 (en) | Pharmaceutical compositions for the sustained release of insoluble active principles | |
| HK1060558A1 (en) | 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof. | |
| ZA968134B (en) | The production of vitamin-containing solid formulations. | |
| AP2001002369A0 (en) | Pharmaceutical complex. | |
| ZA200110539B (en) | Oxazinocarbazoles for the treatment of CNS diseases. | |
| IL120005A (en) | Pharmaceutical compositions for the treatment of the eye | |
| IT1290910B1 (it) | 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive | |
| NZ501365A (en) | Use of low-molecular-weight heparins for preventing and treating central nervous system (CNS) trauma | |
| AU3439897A (en) | Pharmaceutical formulations containing colostrum and their use | |
| WO1999015160A3 (en) | Use of 6,7-substituted 2-aminotetralines suitable for preparing pharmaceutical composition for the therapeutic treatment of inflammatory and/or autoimmune pathologies | |
| SI1017667T1 (en) | 2-Amino-6-methyl-7-acetyl-tetraline and pharmaceutical compositions for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies | |
| NZ517348A (en) | Use of a mycobacterial extract in the treatment of inflammatory bowel disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PF | Patent in force | ||
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20090922 |